FDA chief: COVID, mail mix-up delayed action on baby formula

Baby Formula RecallWASHINGTON (AP) — The head of the Food and Drug Administration is testifying about a series of setbacks that led to a months-long delay in inspecting the plant at the center of a nationwide baby formula shortage.

FDA Commissioner Robert Califf is facing questions Wednesday from House lawmakers probing the formula shortage.

Califf testified that a COVID-19 outbreak at Abbott’s formula plant led the FDA to delay its inspection from late December until January.

Califf also detailed delays following up on a whistleblower complaint alleging serious violations at the baby formula plant last October.

Categories: National News